Cita APA

Hummel, H., Champiat, S., Olmedo García, M. E., He, K., Dowlati, A., Boyer, M., & FELIP, E. (2024). Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.

Citación estilo Chicago

Hummel, Horst-Dieter, Stephane Champiat, María Eugenia Olmedo García, Kai He, Afshin Dowlati, Michael Boyer, y ENRIQUETA FELIP. Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. 2024.

Cita MLA

Hummel, Horst-Dieter, et al. Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. 2024.